Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05574361 · ClinicalTrials.gov registry record · NA
Continued Access Study to Evaluate Performance of the Organ Recovery Systems _LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant (PILOT™_CA)
A NA study of Liver Transplantation, sponsored by Organ Recovery Systems.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 5
- Study locations
NCT05574361 is a NA study of Liver Transplantation that is active but no longer recruiting, run by Organ Recovery Systems. The registered enrollment target is 120 participants, below the 313-participant average among 12 other Liver Transplantation trials with a reported enrollment target (62% lower). The trial reports 5 study locations across 4 states.
The verdict
NCT05574361, a NA study of Liver Transplantation, is active but no longer recruiting, sponsored by Organ Recovery Systems.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 5
- Study locations
Study Summary
To provide continued access for the LLT system to provide additional safety data in support of the PILOT pivotal efficacy and safety trial
Conditions Studied
Interventions
- DEVICE Hypothermic Machine Perfusion
Study Locations (5)
Illinois
- Northwestern Memorial Hospital - Chicago
- University of Chicago Medical Center - Chicago
New Jersey
- Rutgers New Jersey Medical School - Newark
Ohio
- University of Cincinnati Medical Center - Cincinnati
Utah
- Intermountain Medical Center - Murray
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2022-09-19 |
| Est. Completion | 2027-02-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05574361
The ClinicalTrials.gov registry entry for NCT05574361 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 313-participant average among 12 other Liver Transplantation trials with a reported enrollment target (62% lower). The listed sponsor is Organ Recovery Systems, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Liver Transplantation appearing as the primary indexed condition, and to 1 intervention - of which Hypothermic Machine Perfusion is the first listed.
NCT05574361 reports 5 study locations spanning 4 distinct geographic areas - top geographies include Illinois, New Jersey, Ohio.
Frequently Asked Questions
What is clinical trial NCT05574361 about?
NCT05574361 is a clinical study titled "Continued Access Study to Evaluate Performance of the Organ Recovery Systems _LifePort® Liver Transporter System, a Machine Perfusion System, for Liver Transplant (PILOT™_CA)". To provide continued access for the LLT system to provide additional safety data in support of the PILOT pivotal efficacy and safety trial
What is the current status of trial NCT05574361?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2022-09-19. Estimated completion is 2027-02-28.
What conditions does trial NCT05574361 study?
This clinical trial studies the following conditions: Liver Transplantation.
What interventions are being tested in trial NCT05574361?
The interventions under investigation include: Hypothermic Machine Perfusion (DEVICE).
Who is sponsoring clinical trial NCT05574361?
This trial is sponsored by Organ Recovery Systems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05574361 being conducted?
This trial has 5 study locations across Illinois, New Jersey, Ohio, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Liver Transplantation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mediterranean Diet Post-liver Transplantation
RECRUITING · NA
-
Sequential Hypo- and Normo-thermic Perfusion to Preserve Extended Criteria Donor Livers for Transplantation
ACTIVE NOT RECRUITING · NA
-
Study of Resistance Strengthening Versus Ambulation Post-Liver Transplant
COMPLETED · NA
-
HOPE Against Cancer Recurrence in HCC
RECRUITING · Phase 4
-
Reducing Pain With Methadone and Ketamine in Liver Transplant
RECRUITING · Phase 4
-
Immune Tolerance Induction After Liver Transplantation
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.